Search
forResearch 10 of 1000+
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- Safety of Human Papillomavirus Vaccines: A Review
- Safety of testosterone treatment in postmenopausal women
- Safety of dermatologic medications in pregnancy and lactation
- Safety and efficacy of topical minoxidil in the management of androgenetic alopecia
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis
- Safety of testosterone use in women
- Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review
Community 10 of 282
- PP405 2a study was a safety study. Some rational explaining.
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Efficacy and Safety of Oral Dutasteride 0.5 mg Combined with Oral Minoxidil 2.5 mg for Male Androgenetic Alopecia: A Retrospective Cohort Study
- Kintor long term safety phase 3
- Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract
- KX-826: Long-Term Safety Results are out!
- 2.5mg dut safety/price/synergy w/topical fin
- How can I safely apply RU58841 whilst I have children in the house?
- How to safely stop topical finasteride?
- Study: You can safely conceive on Dutasteride
Learn
— no results
Try a deeper search in learn →